|
Protagonist Therapeutics inc (NASDAQ: PTGX) |
|
Protagonist Therapeutics inc
PTGX's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Protagonist Therapeutics Inc 's sales fell
by -88.89 % in the first quarter of 2025 from the same quarter a year ago.
Ranking at No. 251
Major Pharmaceutical Preparations industry recorded
growth of revenues by 4.5 %
Protagonist Therapeutics Inc faced net loss in contrast to the net income a year ago in first quarter of 2025
• More on PTGX's Growth
|
|
Protagonist Therapeutics Inc current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.
Protagonist Therapeutics Inc realized cash reduction of $ -0.52 per share in trailing twelve-month period. |
Company |
111.22 |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 16.76.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.48.
• More on PTGX's Valuation
|
|
|
|
|
Protagonist Therapeutics Inc current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.
Protagonist Therapeutics Inc realized cash outflow of $ -0.52per share in trailing twelve-month period. |
Company |
111.22 |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 16.76.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.48.
Protagonist Therapeutics Inc Price to Book Ratio is at 5.05 lower than Industry Avg. of 35.08. and higher than S&P 500 Avg. of 0.01
• More on PTGX's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com